TMCnet News
Global Viral Partnering 2010-2017: Deal Trends, Players and Financials - Research and MarketsResearch and Markets has announced the addition of the "Global Viral Partnering 2010-2017: Deal trends, players and financials" report to their offering. Global Viral Partnering 2010 to 2017 provides the full collection of Viral disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. The report takes readers through the comprehensive Viral disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Viral deals. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report presents financial deal terms values for Viral deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to aalyse and benchmark the value of current deals. Report scope:
The report includes deals for the following indications:
Global Viral Partnering 2010 to 2017 provides the reader with the following key benefits:
For more information about this report visit http://www.researchandmarkets.com/research/lmqjh9/global_viral
View source version on businesswire.com: http://www.businesswire.com/news/home/20170227005729/en/ |